Journal of Evidence-Based Dental Practice
Volume 8, Issue 2 , Pages 93-94, June 2008

Intravenous Bisphosphonate Therapy may Lead to Osteonecrosis of the Jaw in Multiple Myeloma, Breast, and Prostate Cancer Patients

Professor – Oral Medicine, NSU College of Dental Medicine, 3200 S. University Drive, Fort Lauderdale, FL 33328

Article Title and Bibliographic Information

Incidence of osteonecrosis of the jaw in patients with multiple myeloma and breast or prostate cancer on intravenous bisphosphonate therapy

Wang EP, Kaban LB, Strewler GJ, Raje N, Troulis MJ.

J Oral Maxillofac Surg 2007;65:1328-31

Strength of Recommendation

C

Purpose/Question

To determine the incidence of ONJ in a cohort of patients with multiple myeloma (MM), breast cancer (BC), or prostate cancer (PC) who were receiving intravenous bisphosphonate therapy for an established period of time.

Source of Funding

American Association of Oral and Maxillofacial Surgeons Student Training Award; Office of Enrichment Programs, Harvard Medical School; and the Department of Oral and Maxillofacial Education and Research Fund.

Type of Study/Design

Retrospective chart review

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 20.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1532-3382(08)00069-9

doi:10.1016/j.jebdp.2008.03.018

Journal of Evidence-Based Dental Practice
Volume 8, Issue 2 , Pages 93-94, June 2008

Article Tools